Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 2/3 3Phase 3 2Phase 1/2 1Phase 1 1

Status

Active not recruiting 2Suspended 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 2Carcinoma 2Renal Pelvis and Ureter Urothelial Carcinoma 1Osteosarcoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Gallbladder Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1

Interventions

Platinum 3Magnetic Resonance Spectroscopy 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Immunoglobulin G 2Disulfides 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2pembrolizumab 1durvalumab 1atezolizumab 1Radiotherapy, Image-Guided 1Radiation 1Pilocarpine 1Nivolumab 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Carboplatin 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Oropharyngeal Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT05063552 2026-06-03

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
430 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡